NCT02474238

Brief Summary

No single type of laser or set of laser parameters is appropriate for all type of irides. Pure Nd:YAG laser iridotomy is very effective in the light color irides. It was considered as the gold standard for iridotomy. It, however, is less effective and causes some complication such as iris hemorrhage especially in patients with dark iris.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
82

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2015

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2015

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

June 11, 2015

Completed
6 days until next milestone

First Posted

Study publicly available on registry

June 17, 2015

Completed
3.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2018

Completed
Last Updated

August 27, 2018

Status Verified

August 1, 2018

Enrollment Period

3.3 years

First QC Date

June 11, 2015

Last Update Submit

August 24, 2018

Conditions

Keywords

Iridotomy

Outcome Measures

Primary Outcomes (1)

  • Laser energy

    Total energy used to create patency on the iris

    1-hour

Secondary Outcomes (5)

  • Bleeding

    1-hour

  • Corneal endothelial cell count

    12-month

  • Central corneal thickness

    12-month

  • Patency of iridotomy

    12-month

  • Intraocular pressure spike

    1-hour

Study Arms (2)

The sequential technique

EXPERIMENTAL

By using the double frequency YAG laser to make the initial bore and the Nd:YAG laser to complete the perforation on iris.

Device: The sequential technique

The pure Nd:YAG laser technique

ACTIVE COMPARATOR

By using the pure Nd:YAG to make a complete perforation on iris.

Device: The pure Nd:YAG laser technique

Interventions

By using 'the double frequency YAG laser' to make the initial bore and 'the Nd:YAG laser' to complete the perforation on iris.

The sequential technique

By using 'the pure Nd:YAG laser' to make a complete perforation on iris.

The pure Nd:YAG laser technique

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient in need to have a laser iridotomy
  • primary angle closure glaucoma or
  • primary angle closure or
  • primary angle closure suspect (needed repeated pupil dilation) or
  • fellow eyes of acute angle closure crisis, and
  • Age of at least 18 years, and
  • Dark iris patients (only black and dark brown color)

You may not qualify if:

  • Eye with acute angle closure crisis
  • Active conjunctiva or corneal infection or inflammation
  • Active anterior uveitis
  • History of any prior laser treatment
  • History intraocular surgery
  • Eye with corneal scar
  • Corneal haziness obscure iridotomy site
  • Endothelial cell count less than 1000 cells/mm2 (pre-laser)
  • Iris color other than black or dark brown
  • Inability to sit at the slit lamp to have laser done

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Weerawat Kiddee

Hat Yai, Changwat Songkhla, 90110, Thailand

Location

MeSH Terms

Conditions

Glaucoma, Angle-Closure

Condition Hierarchy (Ancestors)

GlaucomaOcular HypertensionEye Diseases

Study Officials

  • Asst.Prof.Weerawat Kiddee, MD

    Prince of Songkla University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Asst.Prof.Weerawat Kiddee

Study Record Dates

First Submitted

June 11, 2015

First Posted

June 17, 2015

Study Start

May 1, 2015

Primary Completion

August 1, 2018

Study Completion

August 1, 2018

Last Updated

August 27, 2018

Record last verified: 2018-08

Locations